Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer to evaluate Atomwise's platform for drug discovery

Sep. 18, 2018

GlaxoSmithKline patents hepatitis B e-antigen and/or surface antigen secretion inhibitors

Sep. 18, 2018

CRISPR Therapeutics and ViaCyte partner on gene-edited allogeneic stem cell therapies for diabetes

Sep. 18, 2018

Galapagos, AbbVie Sarl present mutant CFTR modulators

Sep. 18, 2018

Phenex Pharmaceuticals identifies aryl hydrocarbon receptor antagonists

Sep. 18, 2018

Toll-like receptor 4 antagonists discovered at TaiwanJ Pharmaceuticals

Sep. 18, 2018

Biogen presents phase II data for BG-00011 in IPF patients

Sep. 18, 2018

FDA lifts partial clinical hold for XMT-1522

Sep. 18, 2018

Patient recruitment starts in two phase II trials of DMX-200 in kidney disease

Sep. 18, 2018

ALZ-801-derived 3-sulfopropanoic acid prevents Abeta42 oligomerization in Alzheimer's disease

Sep. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...